Search research articles
Contact Us
Filters
Showing results (371-380 of 392) with videos related to
Page
of 40
Sort By:
Journal of the National Cancer Institute
|
January 25, 2022
ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications
Tony El Jabbour, Maksym Misyura, Darren Cowzer, et al.
JAMA Network Open
|
August 24, 2022
Outcomes and Molecular Features of Brain Metastasis in Gastroesophageal Adenocarcinoma
Charlton Tsai, Bastien Nguyen, Anisha Luthra, et al.
Cancer
|
June 1, 2022
Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancer
Kenneth H Yu, Jennifer Park, Avni Mittal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 7, 2019
Efficacy of Combined VEGFR1-3, PDGFα/β, and FGFR1-3 Blockade Using Nintedanib for Esophagogastric Cancer
Elizabeth Won, Azfar Basunia, Walid K Chatila, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 2, 2021
Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways
Smita Sihag, Samuel C Nussenzweig, Henry S Walch, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
August 9, 2018
Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer
Sebastian Mondaca, Matthew Margolis, Francisco Sanchez-Vega, et al.
Annals of Surgery
|
February 10, 2023
Durvalumab and PET-Directed Chemoradiation in Locally Advanced Esophageal Adenocarcinoma: A Phase Ib/II Study
Darren Cowzer, Abraham Jing-Ching Wu, Smita Sihag, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 29, 2025
Clinical Implications of The Cancer Genome Atlas Molecular Classification System in Esophagogastric Cancer
Henry S Walch, Raktim Borpatragohain, Justin Jee, et al.
The Oncologist
|
October 2, 2019
Regorafenib in Combination with First-Line Chemotherapy for Metastatic Esophagogastric Cancer
Ryan H Moy, Gustavo Dos Santos Fernandes, Philip Jonsson, et al.
Journal of the National Cancer Institute
|
September 12, 2023
Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer
Melissa A Lumish, Henry Walch, Steven B Maron, et al.
Page
of 40
Search research articles
Search
Showing results (371-380 of 392) with videos related to
Sort By:
Page
of 40
Journal of the National Cancer Institute
|
January 25, 2022
ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications
Tony El Jabbour, Maksym Misyura, Darren Cowzer, et al.
JAMA Network Open
|
August 24, 2022
Outcomes and Molecular Features of Brain Metastasis in Gastroesophageal Adenocarcinoma
Charlton Tsai, Bastien Nguyen, Anisha Luthra, et al.
Cancer
|
June 1, 2022
Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancer
Kenneth H Yu, Jennifer Park, Avni Mittal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 7, 2019
Efficacy of Combined VEGFR1-3, PDGFα/β, and FGFR1-3 Blockade Using Nintedanib for Esophagogastric Cancer
Elizabeth Won, Azfar Basunia, Walid K Chatila, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 2, 2021
Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways
Smita Sihag, Samuel C Nussenzweig, Henry S Walch, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
August 9, 2018
Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer
Sebastian Mondaca, Matthew Margolis, Francisco Sanchez-Vega, et al.
Annals of Surgery
|
February 10, 2023
Durvalumab and PET-Directed Chemoradiation in Locally Advanced Esophageal Adenocarcinoma: A Phase Ib/II Study
Darren Cowzer, Abraham Jing-Ching Wu, Smita Sihag, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 29, 2025
Clinical Implications of The Cancer Genome Atlas Molecular Classification System in Esophagogastric Cancer
Henry S Walch, Raktim Borpatragohain, Justin Jee, et al.
The Oncologist
|
October 2, 2019
Regorafenib in Combination with First-Line Chemotherapy for Metastatic Esophagogastric Cancer
Ryan H Moy, Gustavo Dos Santos Fernandes, Philip Jonsson, et al.
Journal of the National Cancer Institute
|
September 12, 2023
Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer
Melissa A Lumish, Henry Walch, Steven B Maron, et al.
Page
of 40